Dual‑Driven By Material And Performance: In‑Depth Analysis Of The Core Advantages Of Chiba Needles
May 11, 2026
Within the medical needle product portfolio, material selection and performance design directly determine clinical safety, ease of use, and service life. The reason why the Chiba needle has become the preferred puncture device in interventional radiology lies in its dual strengths of premium material selection and performance optimization, fundamentally meeting clinical demands for minimally invasive, precise, and safe procedures.
Biocompatibility represents the fundamental baseline for medical devices and the core criterion for Chiba needle material selection. Clinical puncture needles come into direct contact with human tissues and blood; poor biocompatibility may trigger rejection, inflammation, allergies, and other adverse reactions that seriously compromise procedural safety. Chiba needles are predominantly manufactured from three medical‑grade materials: 304 stainless steel, 316 stainless steel, and nitinol. All undergo rigorous biocompatibility testing and fully comply with safety requirements for human implantation and prolonged contact. They exhibit no toxicity or tissue irritation and minimize post‑puncture inflammation and allergic responses to safeguard patient safety. Among them, medical‑grade 316 stainless steel delivers superior corrosion resistance and biocompatibility. Even under prolonged exposure to bodily fluids and blood, it resists corrosion and heavy‑metal leaching, making it suitable for high‑demand interventional procedures.
The inherent physical properties of these materials endow Chiba needles with outstanding functional advantages. 304 and 316 stainless steel feature high tensile strength, excellent toughness, and deformation resistance. They maintain a stable puncture trajectory without bending during insertion and withstand mechanical stress from puncture and aspiration, eliminating risks of shaft fracture or damage. Their superior corrosion resistance against bodily fluids, drugs, and disinfectants ensures consistent performance throughout the product shelf life. Nitinol combines superelasticity and shape‑memory capability, enabling navigation along curved pathways and enhancing procedural flexibility for complex‑lesion punctures.
Ultra‑slim design constitutes a defining performance advantage of the Chiba needle and the key to true minimally invasive intervention. With outer diameters ranging from 0.7 mm to 1.5 mm, the needle is significantly finer than conventional alternatives. It minimizes cutting and tearing of healthy tissue during penetration, lowering the risk of bleeding, pain, and adhesions. Combined with a precision‑engineered tip, the slim shaft reduces insertion force for easier handling by clinicians and enables precise control of puncture depth and angle - particularly critical for delicate procedures targeting deep organs and micro‑lesions.
Diversified sizing ensures broad clinical adaptability. Shaft lengths range from 15 cm to 30 cm to accommodate varying puncture depths: shorter needles for superficial tissue access and longer variants for deep‑seated lesions, guaranteeing accurate target positioning in every procedure. Outer‑diameter options of 0.7 mm to 1.5 mm support biopsy, aspiration, cholangiography, and vascular access, with dedicated sizes optimized for tissue sampling and high‑flow fluid drainage. This enables "one needle for multiple applications" and precise scenario‑specific matching.
Customizable performance enhancements further strengthen the product's competitive edge. Supported by advanced manufacturing capabilities, parameters including shaft length, outer diameter, tip angle, and surface finishing can be tailored to customer‑supplied 2D/3D drawings or samples. This addresses unmet needs of standardized products by accommodating the unique procedural preferences of different hospitals, departments, and surgical techniques. Manufactured under ISO 9001:2015 and ISO 13485 dual certifications, every Chiba needle undergoes strict process control and finished‑product testing to ensure consistent, high‑quality performance and reliable clinical use.
In summary, built on premium medical‑grade materials and centered on precision, minimal invasiveness, and versatile functionality, Chiba needles establish a clear competitive advantage over conventional medical needles. They resolve core pain points in clinical puncture while improving safety and operability. Against the backdrop of high‑quality development in the medical consumables industry, products with superior material and performance profiles represent both clinical demand and the industry's future direction, providing a valuable benchmark for the R&D and optimization of other medical needle devices.








